The Skin Cancer Foundation Journal

MAY 2014

The 2012 edition of The Skin Cancer Foundation Journal features medically reviewed, reader-friendly articles such as tanning, the increasing incidence of skin cancer diagnoses among young women, & the prevalence of melanoma among white males over 50.

Issue link: https://skincancer.epubxp.com/i/319518

Contents of this Issue

Navigation

Page 97 of 103

9 6 S K I N C A N C E R F O U N DAT I O N J O U R N A L References, Continued 8. Byrd KM, Wilson DC, Hoyler SS. Advanced presenta- tion of melanoma in African Americans. J Am Acad Derma- tol 2004; 50:142-143. AFTER THE DAMAGE IS DONE (P.34) 1. Yarosh D, Klein J, O'Connor A, Hawk J, Rafal E, Wolf P. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a random- ized study. Xeroderma Pigmentosum Study Group. Lancet 2001; 357(9260):926-929. 2. DeBoyes T, Kouba D, Ozog D, Fincher E, Moy L, Iwata K, Moy R. Reduced number of actinic keratoses with topical application of DNA repair enzyme creams. J Drugs Derma- tol 2010; 9(12):1519-1521. 3. Yarosh DB, Alas LG, Yee V, et al. Pyrimidine dimer removal enhanced by DNA repair liposomes reduces the incidence of UV skin cancer in mice. Cancer Res 1992; 52(15):4227-4223. 4. DeBoyes T, Ozog DM, Moy RL. Skin cancer prevention: current modalities and future implications. Federal Practi- tioner 2010; 27(5):40-44. HIGH-TECH THREADS (P.38) 1. Gies P, McLennan A. Ready to wear sun protection: clothing fts the bill. The Skin Cancer Foundation Journal 2012; 30:70-72. 2. Sun Protection Clothing Basics. REI. http://www.rei. com/learn/expert-advice/sun-protection.html. Update Feb- ruary 8, 2014. Accessed April 2, 2014. 3. Adam JE. The role of fabrics in sun protection. The Melanoma Letter 1999; 17:2:1-2, 6. THAT'S NOT OUR DISEASE (P.43) 1. Coups EJ, Stapleton JL, Hudson SV, et al. Linguistic ac- culturation and skin cancer-related behaviors among His- panics in the Southern and Western United States. JAMA Dermatol 2013; 149(6):679-686. 2. Halder RM, Bridgeman-Shah S. Skin cancer in African Americans. Cancer 1995; 75:667-73. 3. Gohara M, Perez M. Skin cancer and skin of color. The Skin Cancer Foundation Journal 2009; 27: 47-52. 4. Gloster HM, Neal K. Skin cancer in skin of color. J Am Acad Dermatol 2006; 55:741-60. 5. Hispanics urged to perform skin self exams, discuss cancer risk with patients. UNC Healthcare and UNC School of Medicine. http://news.unchealthcare.org/news/2013/ august/hispanics-urged-to-perform-skin-self-exams- discuss-cancer-risk-with-physicians. Published August 27, 2013. Accessed April 2, 2014. 6. Hu S, Soza-Vento RM, Parker DF, Kirsner RS. Compari- son of stage at diagnosis of melanoma among Hispanic, black and white patients in Miami-Dade County, Florida. JAMA Dermatol 2006; 142(6):704-708. VIVIAN BUCAY (P.45) 1. National Cancer Institute at the National Institutes of Health, Melanoma Treatment (PDQ). http://www.cancer. gov/cancertopics/pdq/treatment/melanoma/HealthProf essional/Page9#Section_610. Accessed March 13, 2014. ON THE ROAD TO SUN SAFETY (P.46) 1. Koh HK, Geller AC, Miller DR, Grossbart TA, Lew RA. Prevention and early detection strategies for melanoma and skin cancer: Current status. Arch Dermatol 1996; 132:436-442. 2. Parkin DM, Mesher D, Sasieni P. Cancers attributable to solar (ultraviolet) radiation exposure in the UK in 2010. Brit J Cancer 2011; 105:S66-S69. 3. Kim DP, Chabra I, Chabra P, Jones EC. Sunscreen use while driving. J Am Acad Dermatol 2013; 68(6):952-956. 4. Lachiewicz AM, Berwick M, Wiggins CL, Thomas NE. Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology and End Results (SEER) program. Arch Dermatol 2008; 144(4):515-521. 5. Humbert P, MacMary S, Sainthillier J-M, et al. Assess- ment of cumulative exposure to UVA through the study of asymmetrical facial skin aging. Clin Int in Aging 2010; 5:227-284. 6. Butler ST, Fosko SW. Increased prevalence of left-sided skin cancers. J Am Acad Dermatol 2010; 63(6):1006-10. DIARY OF A LIFE CUT SHORT (P.52) 1. Wehner MR, Chren M, Nameth D, et al. Interna- tional prevalence of indoor tanning: a systematic review and meta-analysis. JAMA Dermatol 2014; doi:10.1001/ jamadermatol. 2013.6896. 2. Lazovich D, Vogel RI, Berwick M, Weinstock MA, Ander- son KE, Warshaw EM. Indoor tanning and risk of melanoma: a case-control study in a highly-exposed population. Cancer Epidem Biomar 2010; 19(6):1557-1568. 3. Boniol M, Autier P, Boyle P, Gandini S. Cutaneous melanoma attributable to sunbed use: systematic review and meta-analysis. Brit Med J 2012; 345:e4757. doi: 10.1136/bmj.e4757. WHY IS MELANOMA DEADLIER...? (P.55) 1. Geller AC, Miller DR, Annas GD, Demierre MF, Gil- chrest BA, Koh HK. Melanoma incidence and mortality among US whites, 1969-1999. JAMA 2002; 288:1719-20. 2. American Cancer Society, Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2013:4. 3. Fisher D, Geller A. Disproportionate burden of mela- noma mortality in young US men. JAMA Dermatol 2013; 149(8):903-4. 4. Gamba CS, Clark CA, Keegan THM, Tao L, Swetter SM. Melanoma survival disadvantage in young, non-hispanic white males compared with females. JAMA Dermatol 2013; 149:912-20. 5. Joosse A, de Vries E, Eckel R, et al. Gender differences in melanoma survival; female patients have a decreased risk of metastasis. J Invest Dermatol 2011; 131:719-26. 6. Joose A, Kleeberg UR, Lejeune F, et al. Superior out- come of women with stage I/II cutaneous melanoma: pooled analysis of four European Organisation for Re- search and Treatment of Cancer phase III trials. J Clin Oncol 2012; 30:2240-7. SKIN CANCER TREATMENT (P.60) 1. American Cancer Society. Skin Cancer Facts. Available at: http://www.cancer.org/cancer/cancercauses/sunanduv exposure/skin-cancer-facts. Accessed April 21, 2014. 2. Rogers HW, Weinstock MA, Harris AR, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010; 146(3):283-287. 3. Rogers HW. "Your new study of nonmelanoma skin cancers." Email to The Skin Cancer Foundation March 31, 2010. 4. Squamous Cell Carcinoma. American Academy of Dermatology. http://www.aad.org/skin-conditions/ dermatology-a-to-z/squamous-cell-carcinoma. Accessed August 27, 2012. 5. American Cancer Society. Cancer Facts & Figures 2013. http://www.cancer.org/acs/groups/content/@epidemiology surveilance/documents/document/acspc-036845.pdf. Accessed January 31, 2013. 6. Karia PS, Han J, Schmults CD. Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol 2013; 68(6):957-66. 7. Koh HK, Geller AC, Miller DR, Grossbart TA, Lew RA. Prevention and early detection strategies for melanoma and skin cancer: Current status. Arch Dermatol 1996; 132:436-442. 8. Wehner MR, Chren M-M, Nameth D, et al. Interna- tional prevalence of indoor tanning. A systematic review and meta-analysis. Published online January 29, 2014. JAMA Dermatol doi:10.1001/jamadermatol.2013.6896 . 9. Armstrong BK, Kricker A. The epidemiology of UV- induced skin cancer. J Photochem Photobiol B 2001; 63:8-18. 10. Ting W, Schultz K, Cac NN, et al. Tanning bed exposure increases the risk of malignant melanoma. Int J Dermatol 2007; 46(12):1253-7. 11. Chang AL, Solomon JA, Hainsworth JD, et al. Ex- panded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibi- tor, vismodegib. J Am Acad Dermatol 2014; 70(1):60-9. doi:10.1016/j.jaad.2013.09.012 Epub 2013 Nov 1. 12. Johnson TM, Sondak VK, Bichakjian CK, et al. The role of sentinel lymph node biopsy for melanoma: evidence assessment. J Am Acad Dermatol 2006; 54:19-27. 13. Fox MC, Lao CD, Schwartz JL, et al. Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist: part I: Management of stage III disease. J Am Acad Dermatol 2013 Jan; 68(1):1. 14. National Comprehensive Cancer Network. NCCN Clinical Guidelines in Oncology (NCCN Guidelines), Mela- noma, Version 2.2014. http://www.nccn.org/professionals/ physician_gls/pdf/melanoma.pdf. Accessed December 8, 2013. 15. Rosen T, Harting M, Gibson M. Treatment of Bowen's dis- ease with topical 5% imiquimod cream: retrospective study. Dermatol Surg 2007; 33(4):427-31; discussion 431-2. 16. Cox NH, Eedy DJ, Morton CA. Guidelines for manage- ment of Bowen's disease: 2006 update. Brit J Dermatol 2007; 156(1):11-21. 17. Arits AH, Mosterd K, Essers BA, et al. Photodynamic therapy versus topical imiquimod versus topical fuoro- uracil for treatment of superfcial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial. Lancet Oncol 2013; 14(7):647-54. 18. Truchuelo M, Fernández-Guarino M, Fleta B, et al. Ef- fectiveness of photodynamic therapy in Bowen's disease: an observational and descriptive study in 51 lesions. J Eur Acad Dermatol Venereol 2012; 26(7):868-74. 19. Nguyen TH, Ho DQ. Nonmelanoma skin cancer. Curr Treat Option Onc 2002; 3(3):193-203. 20. Mallon E, Dawber R. Cryosurgery in the treatment of basal cell carcinoma. Assessment of one and two freeze-

Articles in this issue

Links on this page

Archives of this issue

view archives of The Skin Cancer Foundation Journal - MAY 2014